Clinical trial
The VIBLOK SAfety and perFormancE Trial
NCT03080961 is registered in ClinicalTrials.gov with CLJI Worldwide as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The VIBLOK SAfety and perFormancE Trial
- Lead sponsor
- CLJI Worldwide
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 27, 2017
- Completion date
- November 13, 2017
- Enrollment
- 82 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
genital herpes, hsv-2 infection